Real world research on medicines: contribution of the European Network of Centres in Pharmacoepidemiology and Pharmacovigilance (ENCePP)

• Date:
  Monday, 08 March 2021
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

The aim of this 2-hour webinar is to provide the opportunity for academic communities and learned societies to gain a better understanding of:

• what the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) is;
• how ENCePP contributes to improving pharmaco-epidemiological research, particularly in a pandemic situation.

ENCePP members will:

• share their experience in working with the ENCePP tools;
• illustrate how the network supports observational research conducted by academia;
• discuss important methodological aspects of providing high-quality evidence from observational studies to support regulatory and public-health decision-making and related challenges.

Documents

Agenda - Real World research on medicinal products: key contribution of the European Network of Centres in Pharmacoepidemiology and Pharmacovigilance (ENCePP)

AdoptedReference Number: EMA/676969/2020

Presentation - ENCePP webinar for Academia -Real world research on medicines (X. Kurz, F.Salvo, EMA)

Presentation - The EU register of post-authorisation studies: why is it important to register studies and lessons learned? (G.Trifiro, FISPE)

Presentation - How can ENCePP contribute to research? Experience from an EU academic (J.Overbeek, PHARMO)

Presentation - How can ENCePP contribute to research? Experience from a non-EU academics (K.A. Chan, NTUDHRC)

Presentation - ENCePP and COVID-19: Consideration on good practice in observational research on COVID-19 (H. Gardarsdottir, Utrecht University)

Presentation - ENCePP and Covid 19: How does ENCePP contribute to the monitoring of therapeutics and vaccines? (D. Prieto-Alhambra, EHDEN)

Presentation - What has ENCePP achieved and what is next (S. Perez-Gutthann, G. Candore, ENCePP)

Video recording